Comparison of ELISPOT variables between MS-COVID and MS-NCOVID patients at follow-up
| Variable | N | MS-COVID (n=136) | MS-NCOVID (n=186) | P-value* |
| Median CD3 spots/400.000 cells (IQR) | 222 | 1506 (1158; 1810) | 1544 (1076; 1828.5) | 1.00† |
| Median Spike spots/400.000 cells (IQR) | 239 | 307 (142.5; 491.5) | 292 (94; 432) | 1.00† |
| Median Nucleocapsid spots/400.000 cells (IQR) | 251 | 156.5 (44.75; 337.25) | 133 (25; 291) | 1.00† |
*P-values were adjusted with Bonferroni’s correction to account for multiple testing.
†Median regression adjusted for age and sex.
MS, multiple sclerosis.